Elsevier

Atherosclerosis

Volume 106, Issue 2, April 1994, Pages 241-253
Atherosclerosis

Research paper
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

https://doi.org/10.1016/0021-9150(94)90129-5Get rights and content

Abstract

The concentration of plasma LDL subfractions is described in four groups of normocholesterolaemic (total plasma cholesterol < 6.5 mmol/l) male subjects consisting of men with and without coronary artery disease (CAD+/−), as determined by angiography, post-myocardial infarct survivors (PMI) and normal, healthy controls. The CAD(+) and PMI groups were distinguished from the CAD(−) and controls by raised concentrations of plasma triglyceride, very low density lipoprotein (VLDL) cholesterol, small, dense LDL (LDL-III density (d) 1.044–l.060 g/ml) and lower concentrations of high density lipoprotein (HDL) cholesterol and large, buoyant LDL (LDL-I d 1.025–l.034 g/ml). In all groups, a subfraction of intermediate density, LDL-II (d 1.034–1.044 g/ml), was the predominant LDL species but was not related to coronary heart disease risk. Plasma triglyceride showed a positive association with LDL-11 (r = 0.51, P < 0.001) below a triglyceride level of 1.5 mmol/l. Above this threshold of 1.5 mmol/1, LDL-II and LDL-I showed significant negative associations with triglyceride (LDL-11 r = −0.5, P < 0.001; LDL-I r = −0.45, P < 0.001). Small, dense LDL-III showed a weak positive association with triglyceride that became highly significant above the 1.5 mmol/I threshold (r = 0.54, P < 0.001). While age was positively related to LDL-II within the control subjects (r = 0.3, P < 0.05), there was no difference in the percentage abundance or concentration of LDL-III within control and CAD(−) subjects above and below the age of 40 years. Smoking was associated with a relative deficiency of the LDL-I subfraction (LDL-I to LDL-III ratio in smokers = 0.77, in ex-smokers = 0.95, in non-smokers = l.89; P < 0.01), as was β-blocker medication (% LDL-1, users vs. non-users, P < 0.05). Both of these effects could be explained by their primary influence on plasma triglyceride. Analysis of the frequency distributions for the three LDL subfractions revealed the concentration of small, dense LDL-III to be bimodal around a concentration of 100 mg (lipoprotein mass)/ 100 ml plasma. The calculation of odds ratios based on this figure indicated relative risk estimates of 4.5 (ζ2: P < 0.01) for the presence of coronary artery disease and 6.9 (ζ2: P < 0.001) for myocardial infarction. These likelihood scores are greater than those previously described for LDL subclass pattern B as determined by gradient gel electrophoresis and, surprisingly, were maintained after correction for triglyceride, age, body mass index (BMI), smoking and drug status. The present study offers a quantitative description of LDL subfractions in clinically defined coronary artery disease and after myocardial infarction. It offers a plausible explanation for the underlying relationships between LDL subfractions and triglyceride that are operative in healthy and diseased individuals, and demonstrates the value of small, dense LDL as a predictive index of coronary risk status.

References (27)

  • M.A. Austin et al.

    Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease

    Circulation

    (1990)
  • R.A. DeFronzo et al.

    insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease

    Diabetes Care

    (1991)
  • M.J. Caslake et al.

    Plasma triglyceride and low density lipoprotein metabolism

    Eur. J. Clin. Invest.

    (1992)
  • Cited by (502)

    • HAND2-AS1 targeting miR-1208/SIRT1 axis alleviates foam cell formation in atherosclerosis

      2022, International Journal of Cardiology
      Citation Excerpt :

      HDL-C shows negative correlation with the CHD incidence. Protective effects of HDL-C against cardiovascular diseases are usually achieved since HDL participates in RCT [30]. Our data demonstrated that HAND2-AS1 overexpression markedly decreased intracellular lipid accumulation in THP-1-derived macrophages, further supporting the atheroprotective effect of HAND2-AS1.

    View all citing articles on Scopus
    View full text